D'ETTORRE, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 12.072
EU - Europa 5.894
AS - Asia 2.965
AF - Africa 153
SA - Sud America 95
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.193
Nazione #
US - Stati Uniti d'America 11.883
IT - Italia 2.940
SG - Singapore 1.250
IE - Irlanda 636
IN - India 607
SE - Svezia 560
CN - Cina 554
FI - Finlandia 331
MY - Malesia 315
DE - Germania 313
UA - Ucraina 241
RO - Romania 179
CA - Canada 168
RU - Federazione Russa 140
ID - Indonesia 138
GB - Regno Unito 118
BG - Bulgaria 110
TG - Togo 96
AR - Argentina 67
NL - Olanda 59
FR - Francia 56
AT - Austria 47
BE - Belgio 37
CH - Svizzera 23
HK - Hong Kong 21
PL - Polonia 19
EG - Egitto 18
TR - Turchia 18
BR - Brasile 15
ES - Italia 14
MX - Messico 14
LT - Lituania 11
AU - Australia 10
CZ - Repubblica Ceca 10
PH - Filippine 10
ZA - Sudafrica 10
GR - Grecia 8
BJ - Benin 7
IR - Iran 7
KR - Corea 7
SC - Seychelles 7
BZ - Belize 6
CL - Cile 5
ET - Etiopia 5
HR - Croazia 5
MK - Macedonia 5
PE - Perù 5
PK - Pakistan 5
RS - Serbia 5
UG - Uganda 5
JP - Giappone 4
NO - Norvegia 4
PT - Portogallo 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
HU - Ungheria 3
IQ - Iraq 3
LV - Lettonia 3
AD - Andorra 2
AL - Albania 2
AM - Armenia 2
DK - Danimarca 2
EU - Europa 2
GE - Georgia 2
KH - Cambogia 2
KZ - Kazakistan 2
LI - Liechtenstein 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
YE - Yemen 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EC - Ecuador 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 21.193
Città #
Fairfield 1.765
Rome 1.015
Chandler 922
Singapore 908
Woodbridge 838
Ashburn 826
Houston 658
Seattle 629
Dublin 622
Wilmington 561
Cambridge 534
Dearborn 469
Ann Arbor 388
Princeton 353
San Paolo di Civitate 309
Santa Clara 282
Lawrence 235
Plano 198
Fremont 166
Helsinki 165
Millbury 164
Boston 151
San Diego 151
Beijing 149
Jakarta 136
Milan 136
Ottawa 111
Sofia 110
New York 97
Lomé 96
Horia 93
Jacksonville 89
Andover 80
Bremen 73
Boardman 72
San Mateo 68
Federal 66
Norwalk 57
Toronto 49
Des Moines 39
Vienna 34
Brussels 31
Moscow 29
Phoenix 28
Nanjing 27
Dallas 26
Hefei 26
Falls Church 25
London 23
Falkenstein 22
Hebei 22
Kunming 20
Los Angeles 20
Redwood City 20
Bühl 19
Frankfurt am Main 19
Guangzhou 19
Munich 19
Hong Kong 18
Jinan 18
Florence 17
Genoa 17
Mannheim 17
Amsterdam 16
Shanghai 16
Nanchang 15
Nuremberg 15
San Jose 15
Catania 14
Perugia 14
Buffalo 13
Castrovillari 13
Hyderabad 13
Latina 13
Paris 13
Bern 12
Bologna 12
Naples 12
Istanbul 11
Tanta 11
Warsaw 11
Brno 10
Washington 10
Ciampino 9
Lappeenranta 9
Padova 9
Stockholm 9
Tappahannock 9
Lenola 8
Melbourne 8
Mexico City 8
Napoli 8
Pune 8
Shenyang 8
Taurisano 8
Torino 8
Zurich 8
Bari 7
Brescia 7
Chengdu 7
Totale 14.743
Nome #
Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV) 335
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients 162
IFN-α promotes rapid human Treg contraction and late Th1-like Treg decrease 156
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic hepatitis C virus infection 153
Fecal microbial transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent clostridium difficile infection patients 150
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis 149
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents 145
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 142
Analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients 134
Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients 122
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 122
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy 122
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs) 122
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients 121
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients 121
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients. Another COVID-19 paradox 120
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE 118
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease 117
Modulation of tryptophan/serotonin pathway by probiotic supplementation in human immunodeficiency virus-positive patients: preliminary results of a new study approach 113
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial 112
Mobile phone microbial contamination among neonatal unit healthcare workers 110
Probiotics differently affect gut-associated lymphoid tissue indolamine-2, 3-dioxygenase mRNA and cerebrospinal fluid neopterin levels in antiretroviral-treated HIV-1 infected patients: A pilot study 110
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 109
Retinal involvement and ocular findings in COVID-19 pneumonia patients 108
A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features 105
Diagnostic issues of asymptomatic neurosyphilis in HIV-positive patients. A retrospective study 102
Oral bacteriotherapy in patients with COVID-19: a retrospective cohort study 102
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality 101
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 101
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients 100
Challenges in the management of HIV infection. Update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS 99
Challenges in the management of SARS-CoV2 infection. The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19 99
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 98
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients 98
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis 98
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) 98
Nox2 activation in covid-19 96
Assessment of biventricular function by three-dimensional speckle tracking echocardiography in adolescents and young adults with human immunodeficiency virus infection. a pilot study. 95
Infected chronic ischemic wound topically treated with a multi-strain probiotic formulation: a novel tailored treatment strategy 94
Superinfections in patients treated with teicoplanin as anti SARSCoV2 AGENT 94
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients 94
The epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative women and men: a ten-year retrospective observational study in Rome (Italy) 93
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities. Is it time to assess the definitions? 93
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 92
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 91
Expression of the mRNA Levels for MDR1, MRP1, MRP4, and MRP5 IN HIV Antiretroviral Naive Patients: Follow-up at 48 Weeks After the Beginning of Therapy 91
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 91
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients 91
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients 90
Improvement of neuropsychological performances and reduction of immune-activation markers after probiotic supplementation and change of life-style in an HIV positive male: targeting the microbiota to act on gut-brain axis 89
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit 89
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection. A scoping review 88
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy 87
Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients 87
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients 87
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population 87
Ultrasensitive Assessment of Residual HIV Viraemia in HAART-Treated Patients With Persistently Undetectable Plasma HIV-RNA: A Cross-Sectional Evaluation 85
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 85
Type I/II interferon in HIV-1-infected patients: expression in gut mucosa and in peripheral blood mononuclear cells and its modification upon probiotic supplementation 85
Impact of the 2017 measles outbreak on the emergency care system of a large tertiary-care teaching hospital in Italy: A retrospective analysis 85
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation 85
Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection: case report and review of the literature 84
Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients 84
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. 83
Abdominal aortic mycotic aneurysm, psoas abscess, and aorto-bisiliac graft infection due to Salmonella typhimurium. 83
Recovery of interleukin-17 production from interleukin-15-stimulated CD4+ mononuclear cells in HIV-1-infected patients with sustained viral suppression 83
Prevalence and predictors of long corrected QT interval in HIV-positive patients. a multicenter study 83
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients 82
Cardiovascular risk and dyslipidemia among persons living with HIV. A review 82
HIV-2 infection in a migrant from Gambia: the history of the disease combined with phylogenetic analysis revealed the real source of infection 82
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells 81
Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women 81
High HIV-1 diversity in immigrants resident in Italy (2008–2017) 81
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients 81
Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial 80
Carotid artery aneurysm in HIV. A review of case reports in literature 80
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients 79
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection. A case report 79
Hypoalbuminemia, coagulopathy and vascular disease in covid-19 79
Viral community acquired pneumonia at the emergency department: report from the pre COVID-19 age 79
Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects 79
Hospital-acquired infection surveillance in a neonatal intensive care unit 79
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity 79
PRESEPSIN AS A POTENTIAL MARKER FOR BACTERIAL INFECTION RELAPSE IN CRITICAL CARE PATIENTS. A PRELIMINARY STUDY 78
Normocaloric low cholesterol diet modulates th17/treg balance in patients with chronic hepatitis C virus infection. 78
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients 78
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 78
Ozone as adjuvant support in the treatment of covid-19. A preliminary report of probiozovid trial 78
Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases. 78
Diagnosis of anal human papillomavirus infection: polymerase chain reaction or cytology? 77
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. 77
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection 77
The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study) 77
Post-traumatic stress disorder among COVID-19 survivors at 3-month follow-up after hospital discharge 77
Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19. a multicenter observational study 77
HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS 76
Copy-years viremia and risk of virological failure in long-term-treated HIV patients 76
Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial 76
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up 76
Totale 9.881
Categoria #
all - tutte 77.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.879 0 0 0 0 0 0 555 410 381 266 122 145
2020/20212.278 177 213 43 234 101 237 70 134 260 404 157 248
2021/20224.330 150 210 278 219 433 176 136 467 607 242 797 615
2022/20234.390 675 837 228 461 396 321 114 742 325 71 144 76
2023/20242.394 146 306 141 191 232 278 112 268 49 244 211 216
2024/20252.626 187 385 472 449 369 588 176 0 0 0 0 0
Totale 22.349